Emicizumab Prophylaxis in Hemophilia A with Inhibitors

被引：6
|
作者：
Aledort, Louis M. [1 ]
Ewenstein, Bruce M. [2 ]
机构：
[1] Icahn Sch Med, New York, NY 10029 USA
[2] Shire, Cambridge, MA USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 377卷 / 22期
关键词：
D O I：
10.1056/NEJMc1712683
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2193 / 2193
页数：1
相关论文
共 50 条
  • [21] Emicizumab for hemophilia A with factor VIII inhibitors
    Young, Guy
    Callaghan, Michael
    Dunn, Amy
    Kruse-Jarres, Rebecca
    Pipe, Steven
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (11) : 835 - 846
  • [22] Reliable Routine Prophylaxis, Relief for Patients Clinical Experience with Emicizumab in Hemophilia A without Inhibitors
    Neubacher, Daniel
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2019, 46 (04) : 294 - 297
  • [23] RECURRENT INHIBITORS OCCURRED ON EMICIZUMAB PROPHYLAXIS IN A CHILD WITH HEMOPHILIA A WITH INHIBITORS AFTER IMMUNE TOLERANCE INDUCTION: A CASE REPORT
    Li, Z.
    Liu, G.
    Wu, R.
    [J]. HAEMOPHILIA, 2023, 29 : 93 - 94
  • [24] IMPACT OF SWITCHING PROPHYLAXIS TREATMENT FROM FACTOR VIII TO EMICIZUMAB IN HEMOPHILIA A PATIENTS WITHOUT INHIBITORS
    Escobar, Miguel
    Agrawal, Neha
    Chatterjee, Sagnik
    Bhattacharya, Swastik
    Caicedo, Jorge
    Bullano, Michael
    Schultz, Robert G.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E34 - E34
  • [25] Emicizumab: a novel drug in hemophilia A prophylaxis - a narrative review
    Mazurkiewicz, Lukasz
    Czernikiewicz, Krystian
    Rupa-Matysek, Joanna
    Gil, Lidia
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (10) : 933 - 942
  • [26] RESOURCE CONSUMPTION ANALYSIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS ON PROPHYLAXIS WITH FVIII BEFORE SWITCHING TO EMICIZUMAB
    Giacomini, E.
    Leogrande, M.
    Motta, L.
    Tempre, R.
    Bendinelli, S.
    Degli Esposti, L.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S69 - S69
  • [27] A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors
    Young, Guy
    Liesner, Ri
    Chang, Tiffany
    Sidonio, Robert, Jr.
    Oldenburg, Johannes
    Jimenez-Yuste, Victor
    Mahlangu, Johnny
    Kruse-Jarres, Rebecca
    Wang, Michael
    Uguen, Marianne
    Doral, Michelle Y.
    Wright, Lilyan Y.
    Schmitt, Christophe
    Levy, Gallia G.
    Shima, Midori
    Mancuso, Maria Elisa
    [J]. BLOOD, 2019, 134 (24) : 2127 - 2138
  • [28] Impact of switching prophylaxis treatment from factor VIII to emicizumab in hemophilia A patients without inhibitors
    Escobar, Miguel
    Agrawal, Neha
    Chatterjee, Sagnik
    Bhattacharya, Swastik
    Caicedo, Jorge
    Bullano, Michael
    Schultz, Bob G. G.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 574 - 580
  • [29] Serious bleeds in pediatric persons with hemophilia A on emicizumab prophylaxis
    Garcia, Jessica
    Hammer, Matthew R.
    Zia, Ayesha
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (08)
  • [30] An Investigational Dosing Algorithm of Emicizumab for Prophylaxis in Acquired Hemophilia a
    Shima, Midori
    Nagami, Sayaka
    Yoneyama, Koichiro
    Nomura, Akira
    Ogawa, Yoshiyuki
    Amano, Kagehiro
    Nogami, Keiji
    [J]. BLOOD, 2020, 136
12345